Cancer News Round-up.

Item request has been placed! ×
Item request cannot be made. ×
loading   Processing Request
Read Online Read More Add to Saved list
  • Additional Information
    • Subject Terms:
      UNITED States
    • Abstract:
      Presents cancer updates and developments in the U.S. as of November 2004. Positive efficacy results of GlaxoSmithKline PLC's investigatory breast cancer treatment in an ongoing phase II trial; Percentage increase in Dendreon Corp.'s shares after its experimental fast-tracked prostate cancer therapy, Provenge, showed significant survival benefit in patients with advanced prostate cancer; Approval of Aventis Inc.'s Taxotere as therapeutics for hormone-refractory prostate cancer.